Equities

Rossari Biotech Ltd

ROSSARI:NSI

Rossari Biotech Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)912.90
  • Today's Change-4.10 / -0.45%
  • Shares traded75.99k
  • 1 Year change+9.33%
  • Beta1.0018
Data delayed at least 15 minutes, as of Sep 20 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments7081,503640
Total Receivables, Net4,6253,6763,263
Total Inventory3,0681,9892,134
Prepaid expenses121849
Other current assets, total34296.78
Total current assets8,4487,2146,093
Property, plant & equipment, net3,6193,2673,480
Goodwill, net1,1871,187899
Intangibles, net1,4421,5591,706
Long term investments2.872.293.97
Note receivable - long term941385370
Other long term assets33280.88
Total assets15,72213,67612,567
LIABILITIES
Accounts payable2,1911,8101,862
Accrued expenses276880
Notes payable/short-term debt62529084
Current portion long-term debt/capital leases120100--
Other current liabilities, total1,2841,217921
Total current liabilities4,2473,4852,947
Total long term debt442349850
Total debt1,188739935
Deferred income tax515587689
Minority interest------
Other liabilities, total4010229
Total liabilities5,2444,5244,516
SHAREHOLDERS EQUITY
Common stock110110110
Additional paid-in capital4,6864,6414,591
Retained earnings (accumulated deficit)5,6814,4013,351
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity10,4779,1528,052
Total liabilities & shareholders' equity15,72213,67612,567
Total common shares outstanding555555
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.